Found 416 hits.
| 135. | Dressler, C., Werner, R. N., Eisert, L., Zuberbier, T., Nast, A., and Maurer, M.+: Chronic inducible urticaria: a systematic review of treatment options. J. Allergy Clin. Immunol. 2018: 141; 1726-1734. IF: 14.11 |
| 133. | Siiskonen, H., Smorodchenko, A., Krause, K., and Maurer, M.: Ultraviolet radiation and skin mast cells: effects, mechanisms, and relevance for skin diseases. Exp. Dermatol. 2018:27; 3-8. IF: 2.87 |
r.133
| 23. | Church, M. K. and Maurer M.: Action protectrice des éthers phénoliques au course de l’intoxication histaminique (Protective action of phenolic ethers on the course of histamine intoxication) D Bovet and Mlle A-M Staub (20). In: Sheikh, A., Platts-Mills, T., and Worth, A., editors: Landmarks in Allergy Seminal Papers in Allergy with Expert Commentaries. Oxford: University Press, 2013 |
| 99 | Braido, F.+, Bousquet, P. J., Brzoza, Z., Canonica, G. W., Compalati, E., Fiocchi, A., Fokkens, W., Gerth van Wijk, R., La Grutta, S., Lombardi, C., Maurer, M. Pinto, A. M., Ridolo, E., Senna, G. E., Terreehorst, I., Todo Bom, A., Bousquet, J., Zuberbier, T., and Baiardini, I.: Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA²LEN taskforce position paper. Allergy 2010: 65; 959-968. IF: 6.29 |
o.099
| 382. | Bertolin-Collilla, M., Garin-Boronat, O., Siebenhaar, F., Maurer, M., Pujol, R. M., and Giménez-Arnau, A. M.+: Translation and cultural adaption of the German mastocytosis quality of life questionnaire (MC-QoL) into Spanish. Actas Dermosifilogr. 2020: 111; 243-248. IF: N/A |
o.382
| 27. | Młynek, A., Maurer, M., and Zalewska, A.: Update on chronic urticaria: focusing on mechanisms. Curr. Opin. Allergy Clin. Immunol. 2008: 8; 433-437. IF: 3.50 |
| 105. | Maurer, M., Vena, G. A., Cassano, N., and Zuberbier, T.: Current and future therapies for treating chronic spontaneous urticaria. Expert Opin. Pharmacother. 2016: 17; 1131-1139. IF: 3.89 |
r.105
| 99. | Weller, K., Zuberbier, T., and Maurer, M.: Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema. Curr. Opin. Allergy Clin. Immunol. 2015: 15; 220-226. IF: 2.77 |
r.099
| 420. | Weller, K.+, Giménez-Arnau, A., Grattan, C., Asero, R., Mathelier-Fusade, P., Bizjak, M., Hanna, M., and Maurer, M.: The chronic urticaria registry: rationale, methods, and initial implementation. J. Eur. Acad. Dermatol. Venereol. 2021: 35; 721-729. IF: 9.23 |
o.420
| 85. | Maurer, M.: Urticaria and angioedema. History of allergy. Chem. Immunol. Allergy 2014: 100, 101-104. IF N/A |